Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Revive Reschedules Annual and Special Meeting

<< Previous

Bullboard Posts

Next >>

Comment by TheTerminator1on Apr 15, 2021 7:09pm

45 Views

Post# 33008189

RE:RE:Revive Reschedules Annual and Special Meeting

Thank you contribution to this forum

1ottrunner wrote: If these morons are using the same service and hoping we will dial in early to prevent interuption:

I promise you will hear me chime in at 11:15 to announce that ricky, cool, and terminator are morons.

LOLROFLMAO wrote: Revive Reschedules Annual and Special Meeting andProvides Dial-In Information TORONTO, April 15, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (Revive or the Company) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to announce that, further to its press release of April 12, 2021, its Annual and Special Meeting (the Meeting) has been rescheduled to take place on Monday April 19, 2021 at 11:00 a.m. E.D.T. Shareholders and proxyholders may access the Meeting via teleconference by dialing 1-855-327-6838 from Canada or the United States. Due to the high turnout on Monday April 12, 2021, shareholders are encouraged to call into the Meeting at 10:45 a.m. E.D.T. The Meeting will commence promptly at 11:00 a.m.